tiprankstipranks
Trending News
More News >
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
Advertisement

Skye Bioscience (SKYE) Income Statement

Compare
784 Followers

Skye Bioscience Income Statement

Last quarter (Q1 2025), Skye Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Skye Bioscience's net income was $-11.10M. See Skye Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -124.00K$ -115.00K$ -34.13K$ -1.87K
Operating Expenses
$ 36.43M$ 13.55M$ 12.11M$ 7.85M$ 6.29M
Depreciation and Amortization
$ 0.00$ 124.25K$ 115.00K$ 34.13K$ 1.87K
EBITDA
$ 0.00$ -13.55M$ -12.09M$ -7.81M$ -6.29M
Operating Income
$ 0.00$ -13.67M$ -12.11M$ -7.85M$ -6.29M
Other Income/Expenses
$ 0.00$ -23.97M$ -7.37M$ -672.00K$ -270.00K
Pretax Income
$ -26.56M$ -37.64M$ -19.48M$ -8.52M$ -6.56M
Net Income
$ -26.57M$ -37.65M$ -19.48M$ -8.52M$ -6.56M
Per Share Metrics
Basic EPS
$ -0.73$ -5.37$ -9.82$ -5.24$ -7.50
Diluted EPS
$ -0.73$ -5.37$ -10.00$ -5.00$ -7.50
Weighted Average Shares Outstanding
36.49M 7.01M 1.98M 1.63M 922.99K
Weighted Average Shares Outstanding (Diluted)
36.49M 7.01M 1.98M 1.65M 925.68K
Currency in USD

Skye Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis